rs542899681
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_001164458.2(ACTR3C):c.479A>T(p.Asn160Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000249 in 1,609,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164458.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTR3C | ENST00000683684.1 | c.479A>T | p.Asn160Ile | missense_variant | Exon 6 of 8 | NM_001164458.2 | ENSP00000507618.1 | |||
ACTR3C | ENST00000252071.8 | c.479A>T | p.Asn160Ile | missense_variant | Exon 6 of 8 | 1 | ENSP00000252071.4 | |||
ACTR3C | ENST00000478393.5 | c.473A>T | p.Asn158Ile | missense_variant | Exon 5 of 6 | 1 | ENSP00000417426.1 | |||
ACTR3C | ENST00000539352.5 | c.479A>T | p.Asn160Ile | missense_variant | Exon 5 of 5 | 5 | ENSP00000440990.2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152210Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000488 AC: 12AN: 245896 AF XY: 0.0000301 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1457148Hom.: 0 Cov.: 32 AF XY: 0.00000828 AC XY: 6AN XY: 724754 show subpopulations
GnomAD4 genome AF: 0.000138 AC: 21AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74480 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.479A>T (p.N160I) alteration is located in exon 6 (coding exon 5) of the ACTR3C gene. This alteration results from a A to T substitution at nucleotide position 479, causing the asparagine (N) at amino acid position 160 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at